Leiden Dworak - Net Worth and Insider Trading

Leiden Dworak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Leiden Dworak owns 1 companies in total, including TScan Therapeutics Inc (TCRX) .

Click here to see the complete history of Leiden Dworak’s form 4 insider trades.

Insider Ownership Summary of Leiden Dworak

Ticker	Comapny	Transaction Date	Type of Owner
TCRX	TScan Therapeutics Inc	2023-07-21	Chief Accounting Officer

Leiden Dworak Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Leiden Dworak Ownership Network

Ownership Network List of Leiden Dworak

No Data

Ownership Network Relation of Leiden Dworak

Leiden Dworak Owned Company Details

What does TScan Therapeutics Inc do?

Who are the key executives at TScan Therapeutics Inc?

Leiden Dworak is the Chief Accounting Officer of TScan Therapeutics Inc. Other key executives at TScan Therapeutics Inc include Chief Legal Officer Zoran Zdraveski , 10 percent owner Weston Nichols , and 10 percent owner Lynx1 Capital Management Lp .

TScan Therapeutics Inc (TCRX) Insider Trades Summary

Over the past 18 months, Leiden Dworak made no insider transaction in TScan Therapeutics Inc (TCRX). Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 20,000 shares made by Barbara Klencke , a net purchase of 67,027 shares made by Timothy J Barberich , and a net sale of 164,686 shares made by Zoran Zdraveski .

In summary, during the past 3 months, insiders sold 164,686 shares of TScan Therapeutics Inc (TCRX) in total and bought 15,000 shares, with a net sale of 149,686 shares. During the past 18 months, 190,086 shares of TScan Therapeutics Inc (TCRX) were sold and 87,027 shares were bought by its insiders, resulting in a net sale of 103,059 shares.

TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

TScan Therapeutics Inc Insider Transactions

No Available Data

Leiden Dworak Mailing Address

Above is the net worth, insider trading, and ownership report for Leiden Dworak. You might contact Leiden Dworak via mailing address: C/o Tscan Therapeutics, Inc., 880 Winter Street, Waltham Ma 02451.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.